SCCM Pod-504 CCM: Baricitinib or Tocilizumab for Severe COVID-19

SCCM Podcast

תוכן מסופק על ידי SCCM and Society of Critical Care Medicine (SCCM). כל תוכן הפודקאסטים כולל פרקים, גרפיקה ותיאורי פודקאסטים מועלים ומסופקים ישירות על ידי SCCM and Society of Critical Care Medicine (SCCM) או שותף פלטפורמת הפודקאסט שלהם. אם אתה מאמין שמישהו משתמש ביצירה שלך המוגנת בזכויות יוצרים ללא רשותך, אתה יכול לעקוב אחר התהליך המתואר כאן https://he.player.fm/legal.

2M ago 21:43

MP3

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on April 23, 2024 16:03 (27d ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Host Marilyn N. Bulloch, PharmD, BCPS, FCCM, is joined by Joy Peterson, PharmD, BCPS, BCIDP, Neha Paranjape, MD, MPH, to discuss the article, "Outcomes and Adverse Effects of Baricitinib Versus Tocilizumab in the Management of Severe COVID-19," (Crit Care Med. March 2023 51(3):337-346) which delves into the comparative outcomes, mortality rates, and adverse effects of baricitinib and tocilizumab in severe COVID-19 cases. Dr. Peterson is a Clinical Pharmacy Specialist in infectious disease, and Dr. Paranjape is an Infectious Disease Specialist at Wellstar Health System in Marietta, Georgia.

521 פרקים

#Fitness #SCCM #Critical Care #Surgery #Pediatrics #Science #Medicine #Society Of Critical Care Medicine SCCM #ICU #Health and Well-Being